CSIMarket
 
Essa Pharma inc   (NASDAQ: EPIX)
 

Essa Pharma Inc's Customers Performance

EPIX



 
EPIX's Source of Revenues

List of EPIX Customers




for the same period Essa Pharma Inc

List of EPIX Customers





Essa Pharma Inc's Comment on Sales, Marketing and Customers



ESSA Pharmaceuticals focuses on its intellectual property strategy, managing licensing agreements, and maintaining a patent portfolio related to its drug products. The company's portfolio includes the Aniten series and masofaniten (EPI-7386) compounds. ESSA oversees payments and protections associated with these patents and licensing arrangements.


  News about Essa Pharma inc Contracts

Legal Action Looms Bragar Eagel and Squire Unveils Class Action Lawsuits Targeting ESSA, Cardlytics, Novo Nordisk, an...

In a significant announcement on March 20, 2025, Bragar Eagel and Squire, P.C. a prominent law firm specializing in shareholder rights, reminded investors about several active class action lawsuits involving well-known companies: ESSA Pharma Inc. (NASDAQ: EPIX), Cardlytics, Inc. (NASDAQ: CDLX), Novo Nordisk A/S (NYSE: NVO), and Crocs, Inc. (NASDAQ: CROX). These lawsuits aim to protect the interests of shareholders who may have suffered financial losses due to various allegations against these companies. Understanding Class Action LawsuitsClass action lawsuits are legal proceedings in which a group of individuals collectively bring a claim to court, typically because they have suffered similar harm. In the co...




Essa Pharma Inc’s Comment on Sales, Marketing and Customers


ESSA Pharmaceuticals focuses on its intellectual property strategy, managing licensing agreements, and maintaining a patent portfolio related to its drug products. The company's portfolio includes the Aniten series and masofaniten (EPI-7386) compounds. ESSA oversees payments and protections associated with these patents and licensing arrangements.








EPIX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Essa Pharma inc 8.93 0.60 -25.27 18
SUBTOTAL 0.00 0.00 0.00 -

Sources: Essa Pharma inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Essa Pharma inc’s corporate clients.
For your research, we’ve provided 9 tables on Essa Pharma inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.